The aluminium-[18F]fluoride revolution: simple radiochemistry with a big impact for radiolabelled biomolecules

SJ Archibald, L Allott - EJNMMI radiopharmacy and chemistry, 2021 - Springer
Abstract The aluminium-[18F] fluoride ([18F] AlF) radiolabelling method combines the
favourable decay characteristics of fluorine-18 with the convenience and familiarity of metal …

Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment

P Moreno, I Ramos-Álvarez, TW Moody… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: Despite remarkable advances in tumor treatment, many patients still die from
common tumors (breast, prostate, lung, CNS, colon, and pancreas), and thus, new …

A Comprehensive Review of Non-Covalent Radiofluorination Approaches Using Aluminum [18F]fluoride: Will [18F]AlF Replace 68Ga for Metal Chelate Labeling?

C Fersing, A Bouhlel, C Cantelli, P Garrigue… - Molecules, 2019 - mdpi.com
Due to its ideal physical properties, fluorine-18 turns out to be a key radionuclide for positron
emission tomography (PET) imaging, for both preclinical and clinical applications. However …

Prostate cancer theranostics targeting gastrin-releasing peptide receptors

L Baratto, H Jadvar, A Iagaru - Molecular imaging and biology, 2018 - Springer
Gastrin-releasing peptide receptors (GRPRs), part of the bombesin (BBN) family, are
aberrantly overexpressed in many cancers, including those of the breast, prostate, pancreas …

From Unorthodox to Established: The Current Status of 18F-Trifluoroborate- and 18F-SiFA-Based Radiopharmaceuticals in PET Nuclear Imaging

V Bernard-Gauthier, JJ Bailey, Z Liu… - Bioconjugate …, 2016 - ACS Publications
Unorthodox 18F-labeling strategies not employing the formation of a carbon-18F bond are
seldom found in radiochemistry. Historically, the formation of a boron-or silicon-18F bond …

Clinical translation of a dual integrin αvβ3–and gastrin-releasing peptide receptor–targeting PET radiotracer, 68Ga-BBN-RGD

J Zhang, G Niu, L Lang, F Li, X Fan, X Yan… - Journal of Nuclear …, 2017 - Soc Nuclear Med
This study aimed to document the first-in-human application of a 68Ga-labeled
heterodimeric peptide BBN-RGD (bombesin-RGD) that targets both integrin αvβ3 and …

[HTML][HTML] 68Ga-BBN-RGD PET/CT for GRPR and integrin αvβ3 imaging in patients with breast cancer

J Zhang, F Mao, G Niu, L Peng, L Lang, F Li, H Ying… - Theranostics, 2018 - ncbi.nlm.nih.gov
Purpose: This study was to assess a gastrin-releasing peptide receptor (GRPR) and integrin
αvβ3 dual targeting tracer 68 Ga-BBN-RGD for positron emission tomography …

Non-conventional and investigational PET radiotracers for breast cancer: a systematic review

M Balma, V Liberini, M Racca, R Laudicella… - Frontiers in …, 2022 - frontiersin.org
Breast cancer is one of the most common malignancies in women, with high morbidity and
mortality rates. In breast cancer, the use of novel radiopharmaceuticals in nuclear medicine …

Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA) 18F-Radiopharmaceuticals

L Gower-Fry, T Kronemann, A Dorian, Y Pu… - Pharmaceuticals, 2021 - mdpi.com
The incorporation of silicon fluoride acceptor (SiFA) moieties into a variety of molecules,
such as peptides, proteins and biologically relevant small molecules, has improved the …

Bombesin-targeted PET of prostate cancer

R Mansi, R Minamimoto, H Mäcke… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Imaging plays an important role in prostate cancer (PC), including accurate evaluation of the
extent of disease, assessment of sites of recurrent disease, and monitoring of response to …